Table 2.
Gene | Model | Age at time | Region | Effect (increase ↑, decrease ↓, | Reference | ||||
of disruption | SGZ/SVZ | no change ↔, not assessed (na)) | |||||||
Embryo (E) | Stem Cell | Proliferation | Survival | Differentiation | |||||
Adult (A) | Renewal | ||||||||
Ambra1 | In vitro | Neurosphere Assay Ambra1 –/+ KO | E | SVZ | ↓ | ↓ | ↓ | ↓ | [49] |
Atg5 | In vivo | Retroviral Cre Floxed Atg5 | A | SGZ | na | ↔ | ↓ | ↔ | [40] |
In vivo | Retroviral Cre Floxed Atg5/BAX KO | na | ↔ | rescue | ↔ | ||||
In vitro | Neurosphere Assay | E | SGZ, SVZ | ↔ | ↔ | ↔ | ↔ | [50] | |
In vivo | Atg5GFAP cKO | ||||||||
Atg7 | In vitro | Neurosphere Assay | E | SGZ, SVZ | ↔ | ↔ | ↔ | ↔ | [50] |
In vivo | Atg5GFAP cKO | ||||||||
Atg16L1 | In vitro | Neurosphere assay | E | SGZ, SVZ | ↔ | ↔ | ↔ | ↔ | [50] |
In vivo | Atg16L1GFAP cKO | ||||||||
In vivo | ATG16L1 hypomorph | E | SVZ | na | ↓ | ↔ | ↔ | [51] | |
Beclin1 | In vitro | Neurosphere assay | E | SVZ | ↓ | ↓ | ↓ | ↓ | [49] |
In vivo | Beclin1 –/+ | ||||||||
FIP200 | In vitro | Neurosphere assay | E | SGZ, SVZ | ↓ | ↓ | ↓ | ↓ | [47] |
In vivo | FIP200GFAP cKO | ||||||||
In vivo | FIP200;Trp53 cKO | rescue | rescue | ↔ | ↔ | ||||
In vivo | FIP200;p62 cKO | rescue | rescue | rescue | rescue | [50] |